... to the pages of Key Opinions in Medicine (KOM) KOM is a newsletter service delivered by Wiley-Blackwell to update healthcare professionals on new developments across various therapy areas.

KOM began its life with Dermatology and Hematology, but we are constantly trying to broaden our spectrum and grow. We are looking forward to interaction with our readers so please feel free to send questions and comments to us.

Latest Issues

2015 issue 15 Psoriasis (IFPA)

At the 4th World Psoriasis & Psoriatic Arthritis Conference (The International Federation of Psoriasis Associations [IFPA] World Congress 2015, Stockholm, Sweden) a Novartis-sponsored satellite symposium was held to present the latest evidence on meeting the needs of patients with psoriasis and psoriatic arthritis (PsA).

Topic: Dermatology issue: 15/2015

2015 issue 14 Psoriasis (WCD)

A Novartis-sponsored satellite symposium was held at the 23rd World Congress of Dermatology (9 June 2015, Vancouver, Canada) and had the format of a debate, where the faculty were required to take opposing positions. These leading experts debated three questions related to the management of psorias is: 1) Is PASI 90 the new PASI 75? 2) Anti-TNFs as the gold standard for treating psoriatic arthritis: for how much longer? 3) Is it time for biologics as first-line treatment in psoriasis? A lively discussion, chaired by Professor Richard Langley, ensued as the panel presented various arguments related to the treatment expectations of patients, the results of clinical trials, and future perspectives. This Key Opinions in Medicine presents the key points discussed.

Topic: Dermatology issue: 14/2015

2015 Issue 03 Dolutegravir-Basierte Regime

Die in den letzten zwanzig Jahren erzielten Fortschritte in der antiretroviralen Therapie (ART) ermöglichen HIV-infizierten Menschen heute eine weitgehend normale Lebenserwartung (1). Dafür ist jedoch die lebenslange und konsequente Einnahme antiretroviraler Medikamente erforderlich. Daher sind neben hoher und langanhaltender Wirksamkeit auch Langzeitverträglichkeit, hohe Resistenzbarriere und einfache Einnahme für den Langzeiterfolg einer Therapie entscheidend.

Topic: Infectious Diseases issue: 3/2015

2015 issue 13 Urticaria

Chronic urticaria (CU) is a skin disease, characterized by the presence of wheals (hives) and/or angioedema, which last up to 24 hours and reoccur over a period of at least 6 weeks. CU is classified as chronic spontaneous urticaria / chronic idiopathic urticaria (CSU / CIU) or chronic inducible urticaria (CINDU).

Topic: Dermatology issue: 13/2015


KOM is an international publication that can appear in different languages. We offer our sponsors the option to publish across multiple languages or choose one. Please let us know when you need an issue in another language than the one shown.